Federal officials announced a second round of Medicare price negotiations covering 15 more high-cost drugs on January 17, 2025. CMS, CNN, and Fox Business all reported the list and the next step in the Inflation Reduction Act process.

Coverage across the spectrum agreed that the selected drugs accounted for major Medicare spending and that negotiated prices would not take effect immediately. The move built on the first negotiation round and extended one of the Biden era's most consequential health-policy changes.

CNN emphasized projected savings for seniors and taxpayers, while Fox Business focused more on industry criticism and the precedent the program sets for federal involvement in pricing.